Skip to main navigation Skip to search Skip to main content

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

  • Esteban Ortiz-Prado*
  • , Katherine Simbaña-Rivera
  • , Lenin Gómez- Barreno
  • , Mario Rubio-Neira
  • , Linda P. Guaman
  • , Nikolaos C. Kyriakidis
  • , Claire Muslin
  • , Ana María Gómez Jaramillo
  • , Carlos Barba-Ostria
  • , Doménica Cevallos-Robalino
  • , Hugo Sanches-SanMiguel
  • , Luis Unigarro
  • , Rasa Zalakeviciute
  • , Naomi Gadian
  • , Andrés López-Cortés
  • *Corresponding author for this work
  • Universidad de las Americas - Ecuador
  • Hospital Pediátrico Baca Ortiz
  • Universidad Tecnológica Equinoccial
  • Pontificia Universidad Católica del Ecuador
  • Ecuador at Hospital Iess Quito Sur
  • Hospital SOLCA Quito
  • University of Southampton
  • Red Latinoamericana de Implementación y Validación de Guías Clínicas Farmacogenómicas (RELIVAF-CYTED)

Research output: Contribution to journalReview articlepeer-review

316 Scopus citations

Abstract

Coronaviruses are an extensive family of viruses that can cause disease in both animals and humans. The current classification of coronaviruses recognizes 39 species in 27 subgenera that belong to the family Coronaviridae. From those, at least 7 coronaviruses are known to cause respiratory infections in humans. Four of these viruses can cause common cold-like symptoms. Those that infect animals can evolve and become infectious to humans. Three recent examples of these viral jumps include SARS CoV, MERS-CoV and SARS CoV-2 virus. They are responsible for causing severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and the most recently discovered coronavirus disease during 2019 (COVID-19). COVID-19, a respiratory disease caused by the SARS-CoV-2 virus, was declared a pandemic by the World Health Organization (WHO) on 11 March 2020. The rapid spread of the disease has taken the scientific and medical community by surprise. Latest figures from 20 May 2020 show more than 5 million people had been infected with the virus, causing more than 330,000 deaths in over 210 countries worldwide. The large amount of information received daily relating to COVID-19 is so abundant and dynamic that medical staff, health authorities, academics and the media are not able to keep up with this new pandemic. In order to offer a clear insight of the extensive literature available, we have conducted a comprehensive literature review of the SARS CoV-2 Virus and the Coronavirus Diseases 2019 (COVID-19).

Original languageEnglish
Article number115094
JournalDiagnostic Microbiology and Infectious Disease
Volume98
Issue number1
DOIs
StatePublished - Sep 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • Coronavirus
  • Pandemic
  • Review
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review'. Together they form a unique fingerprint.

Cite this